Literature DB >> 28520966

Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.

James I Mullins1, Lisa M Frenkel2,3.   

Abstract

The latent HIV-1 reservoir in blood decays very slowly, even during prolonged suppression of viral replication by antiretroviral therapy (ART). Mechanisms for reservoir persistence include replenishment through low-level viral replication, longevity and homeostatic proliferation of memory T cells, and most recently appreciated, clonal expansion of HIV-infected cells. Clonally expanded cells make up a large and increasing fraction of the residual infected cell population on ART, and insertion of HIV proviruses into certain host cellular genes has been associated with this proliferation. That the vast majority of proviruses are defective clouds our assessment of the degree to which clonally expanded cells harbor infectious viruses, and thus the extent to which they contribute to reservoirs relevant to curing infection. This review summarizes past studies that have defined our current understanding and the gaps in our knowledge of the mechanisms by which proviral integration and clonal expansion sustain the HIV reservoir.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV infected cell proliferation; T-regulatory cells.; cancer genes; clonal proliferation; integration sites

Mesh:

Substances:

Year:  2017        PMID: 28520966      PMCID: PMC6601388          DOI: 10.1093/infdis/jiw636

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

Authors:  Marta E Bull; Jennifer L McKernan; Sheila Styrchak; Kelli Kraft; Jane Hitti; Susan E Cohn; Kenneth Tapia; Wenjie Deng; Sarah Holte; James I Mullins; Robert W Coombs; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-30       Impact factor: 2.205

Review 2.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

3.  Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy.

Authors:  Bradley R Jones; Rachel L Miller; Jeffrey B Joy; Zabrina L Brumme; Natalie N Kinloch; Olivia Tsai; Hawley Rigsby; Hanwei Sudderuddin; Aniqa Shahid; Bruce Ganase; Chanson J Brumme; Marianne Harris; Art F Y Poon; Mark A Brockman; Rémi Fromentin; Nicolas Chomont
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

4.  HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy.

Authors:  Rachel L Miller; Rosalie Ponte; Zabrina L Brumme; Jean-Pierre Routy; Bradley R Jones; Natalie N Kinloch; Fredrick H Omondi; Mohammad-Ali Jenabian; Franck P Dupuy; Remi Fromentin; Pierre Brassard; Vikram Mehraj; Nicolas Chomont; Art F Y Poon; Jeffrey B Joy
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

5.  HIV infection results in clonal expansions containing integrations within pathogenesis-related biological pathways.

Authors:  Kevin G Haworth; Lauren E Schefter; Zachary K Norgaard; Christina Ironside; Jennifer E Adair; Hans-Peter Kiem
Journal:  JCI Insight       Date:  2018-07-12

6.  T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy.

Authors:  Bernard J C Macatangay; Rajesh T Gandhi; Richard B Jones; Deborah K Mcmahon; Christina M Lalama; Ronald J Bosch; Joshua C Cyktor; Allison S Thomas; Luann Borowski; Sharon A Riddler; Evelyn Hogg; Eva Stevenson; Joseph J Eron; John W Mellors; Charles R Rinaldo
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

7.  Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral Therapy.

Authors:  Hsiao-Hsuan Kuo; Riddhima Banga; Guinevere Q Lee; Ce Gao; Matthias Cavassini; Jean-Marc Corpataux; Jane E Blackmer; Schulze Zur Wiesch; Xu G Yu; Giuseppe Pantaleo; Matthieu Perreau; Mathias Lichterfeld
Journal:  J Infect Dis       Date:  2020-07-23       Impact factor: 7.759

Review 8.  Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging.

Authors:  Clovis S Palmer; Riya Palchaudhuri; Hassan Albargy; Mohamed Abdel-Mohsen; Suzanne M Crowe
Journal:  F1000Res       Date:  2018-01-30

9.  Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.

Authors:  Alessandra Ruggiero; Alessandro Cozzi-Lepri; Apostolos Beloukas; Douglas Richman; Saye Khoo; Andrew Phillips; Anna Maria Geretti
Journal:  Open Forum Infect Dis       Date:  2018-02-03       Impact factor: 3.835

10.  Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis.

Authors:  David F Read; Edmond Atindaana; Kalyani Pyaram; Feng Yang; Sarah Emery; Anna Cheong; Katherine R Nakama; Cleo Burnett; Erin T Larragoite; Emilie Battivelli; Eric Verdin; Vicente Planelles; Cheong-Hee Chang; Alice Telesnitsky; Jeffrey M Kidd
Journal:  PLoS Pathog       Date:  2019-10-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.